Skip to content
The GLP-1 Verdict
Menu

Evidence review

Compounded Semaglutide Dosing Errors: What the FDA Safety Alert Says

The FDA has received reports of hospitalizations from dosing errors with compounded semaglutide vials. Here is exactly what goes wrong, and how to avoid it.

By The Verdict Desk, Provider Review Board
On this page

The Verdict's #1 pick

CoreAge Rx

Grade A

The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.

See the verdict
Semaglutide
$149/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Access
Compounded

Advertising disclosure · we may earn a commission at no extra cost to you. It never changes what we write about a product or its Verdict Score.

Also ranked

Sesame Care

Grade B+

An established national telehealth marketplace carrying real brand-name GLP-1s — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — where most programmes we rank carry none, plus provider-by-provider price transparency.

Visit Sesame Care

Compounded semaglutide typically ships as a multi-dose vial you draw up yourself with a syringe — a meaningfully different (and less forgiving) format than the preset, single-dose pens that come with FDA-approved Wegovy and Ozempic. The FDA has now formally flagged what that difference costs in real dosing errors, and it is worth understanding exactly what goes wrong before your first injection, not after.

What the FDA actually said

The FDA issued a direct alert to health care providers, compounders, and patients: "FDA has received reports of adverse events, some requiring hospitalization, that may be related to overdoses due to dosing errors associated with compounded semaglutide injectable products"1. The agency was specific about the mechanism, not vague about it: "Dosing errors have resulted from patients measuring and self-administering incorrect doses of the drug and health care providers miscalculating doses of the drug. Many of the patients who received vials of compounded semaglutide lacked experience with self-injections... unfamiliarity with withdrawing medication from a vial into a syringe... coupled with confusion between different units of measurement (e.g., milliliters, milligrams and 'units') may have contributed to dosing errors"1. A peer-reviewed case series published in the *Journal of the American Pharmacists Association* independently documented the same pattern through calls to a regional poison control center — real administration errors, not a hypothetical risk2.

Why compounded vials are riskier to measure than approved pens

FDA-approved semaglutide products (Wegovy, Ozempic) ship as pre-filled pens that deliver a preset dose — you dial or click to a number the pen enforces mechanically; there is no unit math for the patient to get wrong1. Compounded semaglutide is different by construction: it typically arrives as a multi-dose vial, at a concentration that varies by compounder — and a single compounder may offer multiple different concentrations1. That means the same nominal dose can correspond to a different volume depending on which vial you have, and the burden of getting the math right — converting a prescribed dose in milligrams into the correct volume in milliliters, drawn to the correct mark on an insulin syringe — falls on the patient, often someone self-injecting for the very first time.

The three things that actually cause the errors

Based on the FDA's own account, the errors cluster around three specific points of confusion, not general carelessness: **unit confusion** (mL vs. mg vs. "units" on an insulin syringe are three different scales, and mixing them up produces a dose that's off by a large factor, not a small one); **concentration mismatches** (assuming your vial matches a concentration you saw elsewhere — a chart, a forum post, a friend's vial — rather than the concentration actually printed on your own vial's label); and **syringe mismatch** (using the wrong syringe size for the intended dose, which makes fine measurement harder)1.

How to actually avoid this

**Confirm your vial's concentration in writing before your first dose**, and never assume it matches what you have seen quoted elsewhere. **Ask your provider or pharmacy for the exact syringe size intended for your dose**, and have them walk you through drawing up the first dose live, not just via a written insert. **Never eyeball a conversion between mg, mL, and "units"** — get the specific number worked out for your specific vial, in writing, before you inject. If you have any doubt about a dose you have already drawn up, do not guess; contact your provider or a poison control center before injecting. Our dose calculator converts a prescribed milligram dose into syringe units at a given concentration — a useful cross-check, though it does not replace direct confirmation from your own provider about your own vial.

What this means for choosing a provider

This is a real, quantifiable reason prescriber support has to extend past the point of sale. A provider that ships a vial with a printed insert and nothing else has handed you the exact failure mode the FDA is warning about; one that actively walks new patients through drawing up their first dose has removed it. This is why member support and prescriber access are scored factors in our Verdict Score methodology — not soft, feel-good categories, but a real predictor of whether a patient ends up in this FDA alert's numerator. It is also one more reason to vet the pharmacy itself, which we cover fully in is compounded semaglutide legit and safe. Compare providers on real supported access in the ranked reviews.

This is editorial information, not medical advice. If you are unsure about a dose, contact your provider or a poison control center before administering it.

Frequently asked questions

Has the FDA warned about compounded semaglutide dosing errors?

Yes. The FDA issued a direct alert stating it has received reports of adverse events, some requiring hospitalization, related to overdoses from dosing errors with compounded injectable semaglutide, citing confusion between milliliters, milligrams, and syringe "units" as a key contributor.

Why are compounded vials riskier than an approved pen?

FDA-approved semaglutide pens deliver a preset, mechanically enforced dose. Compounded semaglutide typically ships as a multi-dose vial at a concentration that varies by compounder, requiring the patient to correctly convert a milligram dose into the right syringe volume themselves.

How can I avoid a dosing error with compounded semaglutide?

Confirm your specific vial's concentration in writing, get the correct syringe size from your provider, have your first dose walked through live rather than just via a printed insert, and never guess at a conversion between mg, mL, and syringe units.

References

The 2 sources below are cited in full, and this guide sits alongside the rest of our evidence library, where every claim about the medicine traces to a trial, a label or the regulatory record.

  1. U.S. Food and Drug Administration (2023). FDA Alerts Health Care Providers, Compounders and Patients of Dosing Errors Associated with Compounded Injectable Semaglutide Products. FDA. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
  2. Lambson JE, Flegal SC, Johnson AR, et al. (2023). Administration Errors of Compounded Semaglutide Reported to a Poison Control Center: Case Series. Journal of the American Pharmacists Association. https://pubmed.ncbi.nlm.nih.gov/37392810/

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.